Investing

Top Analyst Upgrades and Downgrades (BUD, BCS, CHKM, CMA, CSC, INTU, LEN, MR, NOK, OAS, RYL, SFD, TXN, TOL, VE)

These are some of this Friday’s top analyst upgrades, downgrades, and initiations seen in Wall Street research notes this morning:

Anheuser-Busch InBev (NYSE: BUD) Started as Buy at Jefferies.
Barclays plc (NYSE: BCS) Cut to Hold at Citigroup.
Chesapeake Midstream Partners (NASDAQ: CHKM) Started as Market Perform at Wells Fargo.
Comerica Inc. (NYSE: CMA) Raised to Outperform at KBW.
Computer Sciences Corp. (NYSE: CSC) Raised to Buy at Jefferies.
Intuit Inc. (NASDAQ: INTU) Cut to Neutral at UBS.
Lennar Corp. (NYSE: LEN) Started as Buy at KeyBanc.
Mindray Medical International Limited (NYSE: MR) Raised to Outperform at Macquarie.
Nokia Corporation (NYSE: NOK) Raised to Outperform at RBC.
Oasis Petroleum Inc. (NYSE: OAS) Started as Outperform at Wells Fargo.
Ryland Group (NYSE: RYL) Started as Buy at KeyBanc.
Smithfield Foods (NYSE: SFD) Cut to Neutral at JPMorgan.
Texas Instruments Inc. (NYSE: TXN) Maintained Buy but lowered price target at Jefferies.
Toll Brothers (NYSE: TOL) Started as Buy at KeyBanc.
Veolia Environnement (NYSE: VE) Cut to Underperform at BNP Paribas.

You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG

Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)

Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.

Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.

Click here now to get started.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.